TABLE 2.

Average abundances for HCMV proteins associated with virions and dense bodies

HCMV ORFVirion abundanceaDense body abundancea
Avg abundanceNo. of peptides usedSDAvg abundanceNo. of peptides usedSD
UL8315.455.360.2236.6
UL48-4912.61<0.14.41<0.1
UL1009.21<0.14.41<0.1
UL329.174.221<0.1
UL828.925.21.750.3
UL488.824.20.820.4
UL807.734.11.11<0.1
UL866112.41.560.6
UL454.71<0.10.920.4
UL852.840.8120.2
UL252.240.812.745.0
UL461.540.70.350.1
UL471.550.60.360.1
UL551.420.40.320.2
UL941.220.511<0.1
IRS10.81<0.10.31<0.1
UL880.740.20.14<0.1
UL770.61<0.1NDNANA
TRS10.620.30.33<0.1
UL750.650.30.630.3
UL350.550.211<0.1
UL1150.520.10.320.1
UL1190.51<0.1NDNANA
UL1320.430.20.220.1
UL1040.420.2NDNANA
US270.21<0.1NDNANA
RL100.22<0.1>0.12<0.1
UL720.21<0.1NDNANA
UL22A0.21<0.1NDNANA
UL970.14<0.10.530.1
UL710.13<0.1NDNANA
UL260.12<0.12.421.0
US220.12<0.1NDNANA
UL1030.15<0.1>0.15<0.1
UL240.11<0.10.51<0.1
UL440.12<0.10.41<0.1
UL330.11<0.1NDNANA
UL43NDNANA0.23<0.1
UL69NDNANA0.13<0.1
UL93NDNANA>0.11<0.1
UL99NDNANA0.520.2
  • a Abundances are based upon a percentage of the total protein present derived from integrated peptide MS peak intensities. ND, not detected; NA, not applicable.